Questions About Cancer? 1-800-4-CANCER
  • Print
  • Facebook
  • Twitter
  • Google+
  • Pinterest

NCI Drug Dictionary


FOLFIRI-cetuximab regimen  Patient Information
A chemoimmunotherapy regimen consisting of leucovorin (folinic acid), 5-fluorouracil, and irinotecan plus cetuximab used for the treatment of metastatic colorectal cancer that is positive for the expression of the epidermal growth factor receptor (EGFR) and the wild-type form of KRAS. (NCI Thesaurus)
Synonyms:FOLFIRI-Erbitux regimen
leucovorin-fluorouracil-irinotecan-cetuximab regimen